Skip to content

effect of Amavatari Rasa in Rheumatoid arthritis(Amavata)

Role of Mercury in the preparation of Amavatari rasa and its effect on Rhumatoid arthritis(Amavata)

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/10/006309
Enrollment
60
Registered
2015-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from Amavata.

Interventions

Intervention1: Group B Amavatari Rasa without mercury : 125 mg thrice in a day anupana luke warm water duration 28 days 14 days follow up Control Intervention1: Group A Amavatari Rasa classical: 125

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having classical symptoms of Amavata will be taken from OPD and IPD of Department of Rasa Shastra and Bhaishajya Kalpana IPGT&RA Jamnagar Angamarda Bodyache Aruchi Anorexia TrishnaThirst Alasya Laziness Gauravam Heaviness Jvara Fever Apaka Indigestion ShunataAnganam Swelling over all body 2 Age of patients will be between 20 to 50 years 3 Modern Criteria for the diagnosis of Rheumatoid arthritis In addition to the classical symptomatology of Amavata as emphasized in Ayurvedic classics Presence of any four of the following criteria based on the revised criteria of American college of Rheumatology 1987 1 Morning stiffness lasting for more than one hour 2 Arthritis of three or more joints 3 Arthritis of hand joints 4 Symmetrical arthritis 5 Presence of rheumatoid nodules 6 Presence of rheumatoid factor 7 Typical Radiographic changes of Arthritis on PA view of Hand and wrist radiograph that must include erosions and unequivocal decalcification adjacent to involve joints Criteria 1 2 3 and 4 must be present for the duration of six weeks or more

Exclusion criteria

Exclusion criteria: Patients having chronic complications like severe crippling deformities and other forms of arthritis like Ankylosing Spondylosis Osteo Arthritis etc Known cases of TB DM HTN cardiac disease liver disease etc Age less than 20 years and more than 50 years

Design outcomes

Primary

MeasureTime frame
Improvement in the signs and symptoms before and after treatment. The Assessment Criterion based on the guidelines provided in the Clinical Research Protocol of CCRAS will be considered for the sameTimepoint: 28 days

Secondary

MeasureTime frame
Improvement in the signs& symptoms before and after treatment. The Assessment Criterion based on the guidelines provided in the Clinical Research Protocol of CCRAS will be considered for the sameTimepoint: 28 days

Countries

India

Contacts

Public ContactProf P K Prajapati

IPGTRA GAU Jamnagar

prajapati.pradeep1@gmail.com9428315733

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026